Pharmafile Logo

The healthcare market research themes for 2014

April 2, 2015 |  

As we shake off our winter coats and prepare for what will hopefully be a long, hot summer, the 2014 themes for healthcare and market research are emerging.

In the US, we have, and will continue to have, the shakedown from the implementation of the Affordable Care Act (aka Obamacare): the teething problems and the confusion, and gradually, so we hope, a clearer picture of what it means for physicians, insurers and patients – and for the industry as a whole. In the UK, we are looking at the implications of an independent Scotland following a referendum which will take place in September. For healthcare, there are some big questions – how would cross-Border healthcare work?  Would the Scottish Intercollegiate Guidelines Network (SIGN) continue to work with NICE? And in parts of Europe, particularly France, data protection laws covering market research are making some of these markets challenging to conduct studies in. Globally, the pharma industry is under increasing scrutiny to demonstrate transparent practices and legal compliance. This requirement transfers to market research suppliers such as Research Partnership, and we need to ensure we are adhering to industry guidelines and clients’ policies with regards to project management processes.

In quantitative research, we are continuing to see a trend towards respondents completing online interviews on smartphones or tablet devices. Questionnaire design and programming is starting to take this into account – it’s very difficult to complete long batteries of rating statements on a tablet simply because the selection options can be so close together. (Hitting the wrong one by accident is sometimes referred to as ‘fat-finger syndrome’!). Online or App surveys specifically designed for smartphone or tablet devices (like our ConferenceLIVE orRxRationale services), are programmed for the device so they are built with the respondent in mind.

We are also witnessing the introduction of other gamification ideas – like giving respondents a time-limit in which to answer spontaneous questions, where the aim is to understand the top-of-mind response, or using icons to replace dry number-rating scales, a range of smiling to frowning faces to indicate satisfaction or dissatisfaction or star ratings. All these tools are designed to make the whole interview experience that bit more engaging, and encourage our respondents to consider their answers.  

Beyond individual pieces of research, the role of online communities of patients or physicians and ‘scraping’ the vast wealth of pre-existing information on the internet (an example of so-called Big Data) are being explored and developed. This isn’t just about counting the number of hits or searches but about identifying and analysing relevant communications and conversations in order to gain insight into the language being used, the information needs as well as resulting behaviour.  

In qualitative research, observation techniques continue to be a trend. As a society, we are becoming more open than ever to sharing information about our daily lives. Qualitative research can benefit from this by using digital, video and face-to-face techniques to garner “uncontaminated” insights from respondents, without the intrusion of a moderator, and gain valuable information about how healthcare stakeholders interact in the real world.

Exciting times to be in healthcare market research. We hold aloft our cooling glass of Pimms and look forward to the summer ahead!

Research Partnership is one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. Find out more here: http://bit.ly/1K6nhJ3

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Forever Angels founder is awarded an MBE

We are delighted to announce that Forever Angels founder Amy Hathaway has been awarded an MBE in this year’s Queen’s Birthday Honours list for providing interim and community care to...

Research Partnership’s Singapore team relocates to new office

We are delighted to announce that our Asia-Pacific team in Singapore has relocated to new premises.

Nutrition Market in Brazil: Growth Against the Odds

Published in eyeforpharma June 2017 by Marc Yates

Research Partnership launches new patient Living with Ulcerative Colitis (UC) US report

Living with Ulcerative Colitis (UC) is a study conducted amongst 100 adult UC patients in the US. The study employs a mixed quantitative/qualitative methodology and will be available to purchase...

Research Partnership is celebrating 20 years in business

Watch our short video to see how we have grown. Please note the video comes with some fun, themed music. https://www.researchpartnership.com/news/2017/06/research-partnership-is-celebrating-20-years-in-bus...

Therapy Watch expands oncology and IBD portfolios

This month Therapy Watch expands its portfolio with the launch of several new trackers across numerous therapy areas including the launch of a new Chronic Myelogenous Leukaemia (CML) study in...

Research Partnership announces several new appointments

Research Partnership is delighted to welcome Anne Cunningham and Morten Andersen and announce that Sue Rees has joined our specialist Emerging Markets team.

PMRC San Francisco 2017

We are delighted to be presenting a paper and exhibiting at the Pharmaceutical Market Research Conference 13-14 June in Bay Area close to our new office in San Francisco.Representing Research...

EphMRA Annual Conference 2017

Visit us on stand number 14

Richard Head nominated for EphMRA Award

We are delighted to announce that Research Partnership’s Director Richard Head has been nominated for The EphMRA President’s Award for Contribution to Pharmaceutical Market Research.According to EphMRA, Richard has been...